Outpost Medicine

United States
Indianapolis, Indiana, United States, 46240

Company profile

Outpost Medicine company profile

At Outpost, they are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).

Business identity

Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2016-01-01, Year

Headquarters

Postal code
46240
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$61M
Last funding
Series A / $20M / 2017-11-15
Last equity funding
Series A / $20M
Investors
6
Lead investors
1
Founders
4
Articles
1
Closed on
2023-08-15

Founders and investors

Founders

David SocksGordon McMurrayScott ByrdTadataka Yamada

Lead investors

Frazier Healthcare Partners

Investors

Adams Street PartnersFrazier Healthcare PartnersNovo HoldingsTakedaVivo Capital